Suspension of AstraZeneca COVID-19 vaccine in the EU Maldita.es
categories
resources used
Talk to official sources
Talk to the source involved
Official sources (communications, databases, BOE)
on 27 March 2024 European Commission withdrew, at the request of AstraZeneca, marketing authorization of the COVID-19 vaccine developed by the pharmaceutical company. The withdrawal will be effective from May 7. The reason, as stated by AstraZeneca Shame!There is development of “several updated vaccines for COVID-19 variants”, which has led to an “overabundance of vaccines available”.
This is why it happened ,decrease in demand From Vaxzervariya (name of the vaccine), which is no longer manufactured or supplied, AstraZeneca requested suspension until March 7, 2024.
They confirm from the Spanish Agency for Medicines and Health Products (AEMPS) Shame! It was the pharmaceutical company itself that has requested the withdrawal of the vaccine at European level, without the need to justify the decision. “This is not unusual. Enter generality. This happens when the company no longer has interest in it for whatever reason,” he points out on behalf of AEMPS.
AstraZeneca admitted for the first time that its Covid vaccine “may cause rare side effects”, the pharmaceutical company requested before the material was published.
As AstraZeneca requested this suspension on March 7, 2024, this was before The Telegraph published it on April 27. ‘AstraZeneca admits for the first time that its Covid vaccine may cause rare side effects, In fact, this potential “very rare” side effect of the vaccine is known thrombosis syndrome with thrombocytopenia. From April 2021,